These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678 [TBL] [Abstract][Full Text] [Related]
5. Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants. Conway KA; Lee SJ; Rochet JC; Ding TT; Harper JD; Williamson RE; Lansbury PT Ann N Y Acad Sci; 2000; 920():42-5. PubMed ID: 11193175 [No Abstract] [Full Text] [Related]
6. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein. Choi W; Zibaee S; Jakes R; Serpell LC; Davletov B; Crowther RA; Goedert M FEBS Lett; 2004 Oct; 576(3):363-8. PubMed ID: 15498564 [TBL] [Abstract][Full Text] [Related]
7. Structure/function of alpha-synuclein in health and disease: rational development of animal models for Parkinson's and related diseases. Kahle PJ; Haass C; Kretzschmar HA; Neumann M J Neurochem; 2002 Aug; 82(3):449-57. PubMed ID: 12153470 [No Abstract] [Full Text] [Related]
8. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Zarranz JJ; Alegre J; Gómez-Esteban JC; Lezcano E; Ros R; Ampuero I; Vidal L; Hoenicka J; Rodriguez O; Atarés B; Llorens V; Gomez Tortosa E; del Ser T; Muñoz DG; de Yebenes JG Ann Neurol; 2004 Feb; 55(2):164-73. PubMed ID: 14755719 [TBL] [Abstract][Full Text] [Related]
9. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein]. Iwatsubo T Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099 [TBL] [Abstract][Full Text] [Related]
10. SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Johnson J; Hague SM; Hanson M; Gibson A; Wilson KE; Evans EW; Singleton AA; McInerney-Leo A; Nussbaum RL; Hernandez DG; Gallardo M; McKeith IG; Burn DJ; Ryu M; Hellstrom O; Ravina B; Eerola J; Perry RH; Jaros E; Tienari P; Weiser R; Gwinn-Hardy K; Morris CM; Hardy J; Singleton AB Neurology; 2004 Aug; 63(3):554-6. PubMed ID: 15304594 [TBL] [Abstract][Full Text] [Related]
11. How not to synthesize synuclein. Wilhelmsen KC Neurology; 2004 Sep; 63(5):770-1. PubMed ID: 15365120 [No Abstract] [Full Text] [Related]
12. Protein degradation in Alzheimer's disease and aging of the brain. Tsuji T; Shimohama S Prog Mol Subcell Biol; 2002; 29():43-60. PubMed ID: 11908072 [No Abstract] [Full Text] [Related]
13. The role of alpha-synuclein gene multiplications in early-onset Parkinson's disease and dementia with Lewy bodies. Hofer A; Berg D; Asmus F; Niwar M; Ransmayr G; Riemenschneider M; Bonelli SB; Steffelbauer M; Ceballos-Baumann A; Haussermann P; Behnke S; Krüger R; Prestel J; Sharma M; Zimprich A; Riess O; Gasser T J Neural Transm (Vienna); 2005 Sep; 112(9):1249-54. PubMed ID: 15622440 [TBL] [Abstract][Full Text] [Related]
14. Age-associated prevalence and risk factors of Lewy body pathology in a general population. Jellinger KA Acta Neuropathol; 2003 Oct; 106(4):383-4. PubMed ID: 12904993 [No Abstract] [Full Text] [Related]
15. A new link between pesticides and Parkinson's disease. Giasson BI; Lee VM Nat Neurosci; 2000 Dec; 3(12):1227-8. PubMed ID: 11100135 [No Abstract] [Full Text] [Related]